Predictive Role of Acute Phase Reactants in the Response to Therapy in Patients with Chronic Hepatitis C Virus Infection
Authors:
Open Access
- 15 January 2013
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 7 (1) , 82-88
Abstract
Oguz A, et al. Gut Liver. 2013 Jan;7(1):82-88. http://dx.doi.org/10.5009/gnl.2013.7.1.82Keywords
This publication has 44 references indexed in Scilit:
- Chronic Hepatitis CGut and Liver, 2011
- Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patientsHepatology International, 2010
- Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AIJournal of Biomedical Science, 2010
- Transient CD86 Expression on Hepatitis C Virus-Specific CD8+ T Cells in Acute Infection Is Linked to Sufficient IL-2 SignalingThe Journal of Immunology, 2010
- Association of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul StudyJournal of Cardiac Failure, 2009
- Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C†Hepatology, 2008
- Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsJournal of Hepatology, 2004
- Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C*1Journal of Hepatology, 2004
- Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infectionDigestive Diseases and Sciences, 1995
- Alpha-2-macroglobulin and hepatic fibrosisDigestive Diseases and Sciences, 1994